title: Unresectable locally advanced pancreatic cancer: treatment with neoadjuvant leucovorin, fluorouracil, irinotecan, and oxaliplatin and assessment of surgical resectability.
authors.affiliation: University of Rochester Medical Center School of Medicine and Dentistry, Rochester, NY 14642, USA.
authors.forename: Esther Liu
authors.initials: EL
authors.lastname: Mondo
authors.forename: Marcus S
authors.initials: MS
authors.lastname: Noel
authors.forename: Alan W
authors.initials: AW
authors.lastname: Katz
authors.forename: Luke O
authors.initials: LO
authors.lastname: Schoeniger
authors.forename: Aram F
authors.initials: AF
authors.lastname: Hezel
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives; D021441:Carcinoma, Pancreatic Ductal / Q000188:drug therapy* / Q000473:pathology* / Q000601:surgery; D006801:Humans; D000077146:Irinotecan; D002955:Leucovorin / Q000008:administration & dosage; D008297:Male; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077150:Oxaliplatin; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000473:pathology* / Q000601:surgery
chemical_list: D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D000077146:Irinotecan; D002955:Leucovorin; D002166:Camptothecin